Insiders Trades
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (23 ops.)
Latest filing published 26 Jun 2026 for Ionis Pharmaceuticals INC. Read the official filing
Filing timeline
BuySaleBrett P. Monia
Insider track record
Disclosed buys
0
Disclosed sells
23
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Brett P. Monia: trading record in brief
Brett P. Monia, listed as chief executive, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Ionis Pharmaceuticals Inc and Cognition Therapeutics Inc. We count 60 filings; the first trade dates from 1 January 2016 and the latest from 26 June 2026.
Sales make up the whole of the open-market record (23 sales, €6.9M). No amount is published for 9 filings, which the totals therefore leave out. Besides market trades, the filings include 9 share grants and 19 option exercises. So far in 2026, the count stands at no purchases and 4 sales.
The newest entry dates from 26 June 2026: an option exercise, in Ionis Pharmaceuticals Inc. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Brett P. Monia
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations60 total
14,565 sharesCommon StockSEC:0000874015-26-000212:0
14,565 sharesCommon StockSEC:0000874015-26-000212:1
21,072 sharesCommon StockSEC:0000874015-26-000212:2
21,072 sharesCommon StockSEC:0000874015-26-000212:3
50,000 sharesCommon StockSEC:0000874015-26-000212:4
50,000 sharesCommon StockSEC:0000874015-26-000212:5
25,000 sharesCommon StockSEC:0001104659-26-076475:0
1,316 shares@ US$32.600.0003% mcap0.3% of flowCommon StockSEC:0000874015-26-000185:0
40,822 shares@ US$60.890.017% mcap15.5% of flowCommon StockSEC:0000874015-26-000143:0
484 shares@ US$48.86650.1% of flowCommon StockSEC:0000874015-26-000123:0
29,430 shares@ US$85.790714.3% of flowCommon StockSEC:0000874015-26-000106:0
122,214 shares0Common StockSEC:0000874015-26-000099:0
89,145 shares0Common StockSEC:0000874015-26-000069:0
437 shares@ US$69.26370.2% of flowCommon StockSEC:0000874015-25-000252:0
102,900 shares@ US$53.770.037% mcap34.1% of flowCommon StockSEC:0000874015-25-000221:0
189 shares@ US$27.710.0% of flowCommon StockSEC:0000874015-25-000191:0
2,432 shares@ US$32.600.5% of flowCommon StockSEC:0000874015-25-000170:0
1,160 shares@ US$41.73810.3% of flowCommon StockSEC:0000874015-25-000146:0
34,000 shares0Common StockSEC:0001062993-25-012078:0
140 shares@ US$32.320.0% of flowCommon StockSEC:0000874015-25-000105:0
437 shares@ US$28.21150.1% of flowCommon StockSEC:0000874015-25-000101:0
38,843 shares@ US$31.65216.1% of flowCommon StockSEC:0000874015-25-000084:0
25,372 shares0Common StockSEC:0000874015-25-000078:0
73,448 shares0Common StockSEC:0000874015-25-000062:0
6,630 shares@ US$38.05341.2% of flowCommon StockSEC:0000874015-24-000240:0
25 of 60 declarations
